Updated results of PEANUT trial: Pembrolizumab and nabpaclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma (mUC)

被引：0
|
作者：
Bottiglieri, A. [1 ]
Bravo, W. Ferrari [1 ]
Rametta, A. [1 ]
Provenzano, L. [1 ]
Raggi, D. [2 ]
Marandino, L. [2 ]
Fare, E. [3 ]
Longo, V. [1 ]
Guadalupi, V. [1 ]
Stellato, M. [1 ]
Verzoni, E. [1 ]
Sepe, P. [1 ]
Claps, M. [1 ]
Calareso, G. [4 ]
Alessi, A. [5 ]
Cattaneo, L. [6 ]
Colecchia, M. [7 ]
Procopio, G. [1 ]
Necchi, A. [2 ]
Giannatempo, P. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[2] IRCCS Osped San Raffaele, Dept Med Oncol, Milan, Italy
[3] Osped Civile Legnano, Dept Med Oncol, Legnano, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Dept Intervent Radiol, Milan, Italy
[5] Fdn IRCCS Ist Nazl Tumori, Dept Nucl Med, Milan, Italy
[6] Fdn IRCCS Ist Nazl Tumori, Adv Diagnost Dept, Milan, Italy
[7] IRCCS Osped San Raffaele, Dept Pathol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2370P
引用
收藏
页码：S1206 / S1206
页数：1
相关论文
共 50 条
  • [1] Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): outcomes by prior therapy
    von Amsberg, G.
    Perez-Garcia, J. L.
    Loriot, Y.
    Rosenberg, J. E.
    Powles, T.
    Necchi, A.
    Hussain, S. A.
    Morales-Barrera, R.
    Retz, M.
    Niegisch, G.
    Duran, I.
    Theodore, C.
    Grande, E.
    Thastrom, A. C.
    Li, S.
    Abidoye, O. O.
    Van Der Heijden, M. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 115 - 115
  • [2] Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy.
    Perez-Gracia, Jose Luis
    Loriot, Yohann
    Rosenberg, Jonathan E.
    Powles, Thomas
    Necchi, Andrea
    Hussain, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study
    Giannatempo, P.
    Raggi, D.
    Marandino, L.
    Bandini, M.
    Fare, E.
    Calareso, G.
    Colecchia, M.
    Gallina, A.
    Ross, J. S.
    Alessi, A.
    Briganti, A.
    Montorsi, F.
    Madison, R.
    Necchi, A.
    ANNALS OF ONCOLOGY, 2020, 31 (12) : 1764 - 1772
  • [4] IMvigor 210, a phase II trial of atezolizumab (MPDL3280A) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC).
    Hoffman-Censits, Jean H.
    Grivas, Petros
    Van der Heijden, Michiel Simon
    Dreicer, Robert
    Loriot, Yohann
    Retz, Margitta
    Vogelzang, Nicholas J.
    Perez-Gracia, Jose Luis
    Rezazadeh, Arash
    Bracarda, Sergio
    Yu, Evan Y.
    Hoimes, Christopher J.
    Bellmunt, Joaquim
    Quinn, David I.
    Petrylak, Daniel Peter
    Hussain, Syed A.
    Cui, Na
    Mariathasan, Sanjeev
    Abidoye, Oyewale O.
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens
    Luis Perez-Gracia, Jose
    Loriot, Yohann
    Rosenberg, Jonathan E.
    Powles, Thomas
    Necchi, Andrea
    Hussain, Syed A.
    Morales-Barrera, Rafael
    Retz, Margitta M.
    Niegisch, Gunter
    Duran, Ignacio
    Theodore, Christine
    Grande, Enrique
    Shen, Xiaodong
    Wang, Jingjing
    Nelson, Betty
    Derleth, Christina L.
    van der Heijden, Michiel S.
    EUROPEAN UROLOGY, 2018, 73 (03) : 462 - 468
  • [6] Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Safety analysis from an expanded access study.
    Bellmunt, Joaquim
    Pal, Sumanta K.
    Zheng, Hanzhe
    Tayama, Darren
    Chang, Dannis
    Hoffman-Censits, Jean H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Atezolizumab for platinum-treated metastatic urothelial carcinoma
    Massari, Francesco
    Di Nunno, Vincenzo
    LANCET, 2018, 391 (10122): : 716 - 718
  • [8] Atezolizumab (atezo) in special populations: Analyses from an expanded access program (EAP) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC)
    Hoffman-Censits, Jean H.
    Pal, Sumanta K.
    Zheng, Hanzhe
    Tayama, Darren
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Post-progression outcomes from the phase 2 IMvigor210 study
    Necchi, A.
    Joseph, R. W.
    Loriot, Y.
    Hoffman-Censits, J.
    Perez Gracia, J. L.
    Petrylak, D. P.
    Zhu, Q.
    Ding, B.
    Kaiser, C.
    Rosenberg, J. E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States
    Pal, Sumanta Kumar
    Hoffman-Censits, Jean
    Zheng, Hanzhe
    Kaiser, Constanze
    Tayama, Darren
    Bellmunt, Joaquim
    EUROPEAN UROLOGY, 2018, 73 (05) : 800 - 806
12345